Cargando…

A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma

We present a generic dendritic cell (DC) vaccine strategy for patients with renal cell carcinoma (RCC) based on the use of RNA as a source of multiplex tumor-associated antigens (TAAs). Instead of preparing RNA from tumor tissue of each individual RCC patient, we propose to substitute RNA prepared f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geiger, Christiane, Regn, Sybille, Weinzierl, Andreas, Noessner, Elfriede, Schendel, Dolores J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188079/ https://www.ncbi.nlm.nih.gov/pubmed/16045799 http://dx.doi.org/10.1186/1479-5876-3-29

Ejemplares similares

Generation of allo-restricted peptide-specific T cells using RNA-pulsed dendritic cells: A three phase experimental procedure
por: Wilde, Susanne, et al.
Publicado: (2012)

Three-day dendritic cells for vaccine development: Antigen uptake, processing and presentation
por: Bürdek, Maja, et al.
Publicado: (2010)

T-Cells Expressing a Highly Potent PRAME-Specific T-Cell Receptor in Combination with a Chimeric PD1-41BB Co-Stimulatory Receptor Show a Favorable Preclinical Safety Profile and Strong Anti-Tumor Reactivity
por: Sailer, Nadja, et al.
Publicado: (2022)

Intratumoral alterations of dendritic-cell differentiation and CD8(+) T-cell anergy are immune escape mechanisms of clear cell renal cell carcinoma
por: Noessner, Elfriede, et al.
Publicado: (2012)

Effects of TLR agonists on maturation and function of 3-day dendritic cells from AML patients in complete remission
por: Beck, Barbara, et al.
Publicado: (2011)

NOD/scid IL-2Rg(null )mice: a preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivo
por: Spranger, Stefani, et al.
Publicado: (2012)

P55. Dendritic cell vaccination for postremission therapy in AML
por: Lichtenegger, FS, et al.
Publicado: (2014)

Next-generation dendritic cells for immunotherapy of acute myeloid leukemia
por: Schnorfeil, Frauke, et al.
Publicado: (2014)

Dendritic Cells or Macrophages? The Microenvironment of Human Clear Cell Renal Cell Carcinoma Imprints a Mosaic Myeloid Subtype Associated with Patient Survival
por: Brech, Dorothee, et al.
Publicado: (2022)

Identification of EZH2 as Cancer Stem Cell Marker in Clear Cell Renal Cell Carcinoma and the Anti-Tumor Effect of Epigallocatechin-3-Gallate (EGCG)
por: Lyu, Chen, et al.
Publicado: (2022)

A novel and effective method to generate human porcine-specific regulatory T cells with high expression of IL-10, TGF-β1 and IL-35
por: Li, Mingqian, et al.
Publicado: (2017)

Co-Regulation of Immune Checkpoint PD-L1 with Interferon-Gamma Signaling is Associated with a Survival Benefit in Renal Cell Cancer
por: Hänze, Jörg, et al.
Publicado: (2020)

Checkpoint Inhibition in Bladder Cancer: Clinical Expectations, Current Evidence, and Proposal of Future Strategies Based on a Tumor-Specific Immunobiological Approach
por: Mancini, Mariangela, et al.
Publicado: (2021)

DGK-α: A Checkpoint in Cancer-Mediated Immuno-Inhibition and Target for Immunotherapy
por: Noessner, Elfriede
Publicado: (2017)

Zoledronate-pulsed dendritic cell-based anticancer vaccines
por: Kamigaki, Takashi, et al.
Publicado: (2013)

Turning tumor inhibition into activation: engineering T cells with chimeric signaling receptors
por: Schlenker, Ramona, et al.
Publicado: (2014)

Ex vivo pulsed dendritic cell vaccination against cancer
por: Gu, Yang-zhuo, et al.
Publicado: (2020)

Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer
por: Ding, Zhenyu, et al.
Publicado: (2021)

Administration route-dependent vaccine efficiency of murine dendritic cells pulsed with antigens
por: Okada, N, et al.
Publicado: (2001)

Reduction of liver metastases outgrowth by tumour antigen-pulsed dendritic cell vaccination
por: Mels, Anna K, et al.
Publicado: (2004)

Investigation of the Immunomodulatory effect of Berberis vulgaris on core-pulsed dendritic cell vaccine
por: Ghareeb, Doaa A., et al.
Publicado: (2016)

Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70
por: Zobywalski, Anke, et al.
Publicado: (2007)

Ewing Sarcoma-Derived Extracellular Vesicles Impair Dendritic Cell Maturation and Function
por: Gassmann, Hendrik, et al.
Publicado: (2021)

Dendritic Cells Pre-Pulsed with Wilms’ Tumor 1 in Optimized Culture for Cancer Vaccination
por: Koya, Terutsugu, et al.
Publicado: (2020)

P21. NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention
por: Prinz, P, et al.
Publicado: (2014)

Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy
por: Olguín-Contreras, Luis Felipe, et al.
Publicado: (2021)

CD86 and IL-12p70 Are Key Players for T Helper 1 Polarization and Natural Killer Cell Activation by Toll-Like Receptor-Induced Dendritic Cells
por: Lichtenegger, Felix S., et al.
Publicado: (2012)

Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer
por: de Bruijn, Sévérine, et al.
Publicado: (2019)

Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer
por: Mehrotra, Shikhar, et al.
Publicado: (2017)

Dendritic Cell Based Tumor Vaccination in Prostate and Renal Cell Cancer: A Systematic Review and Meta-Analysis
por: Draube, Andreas, et al.
Publicado: (2011)

Eliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens: evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccination
por: Wei, Fan-Qin, et al.
Publicado: (2016)

Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
por: Zhang, Rui, et al.
Publicado: (2019)

Molecular Characterization of Antigen-Peptide Pulsed Dendritic Cells: Immature Dendritic Cells Develop a Distinct Molecular Profile when Pulsed with Antigen Peptide
por: Yang, Amy X., et al.
Publicado: (2014)

Targeting dendritic cells: a promising strategy to improve vaccine effectiveness
por: Macri, Christophe, et al.
Publicado: (2016)

A Generic Timing Software for Fast Pulsed Magnet Systems at CERN
por: Chanavat, Christophe, et al.
Publicado: (2015)

Whole tumor antigen vaccination using dendritic cells: Comparison of RNA electroporation and pulsing with UV-irradiated tumor cells
por: Benencia, Fabian, et al.
Publicado: (2008)

P31. Genomic profiling and functional characterisation of a new myeloid cell type enriched in renal cell carcinoma
por: Brech, D, et al.
Publicado: (2014)

Strategies to improve the immunogenicity of anticancer vaccines based on dendritic cell/malignant cell fusions
por: Koido, Shigeo, et al.
Publicado: (2013)

GENETIC CONTROL OF CELL-MEDIATED LYMPHOLYSIS IN MOUSE
por: Schendel, Dolores J., et al.
Publicado: (1974)

Progressive natural killer cell dysfunction associated with alterations in subset proportions and receptor expression in soft-tissue sarcoma patients
por: Bücklein, Veit, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ff7kfrdbo4cmc89arvpk10k6vp